Navi
Right
 
 
Skip Navigation LinksHome Press releases Companies Focused Towards Developing Novel Vertigo Drug
press release details
Companies Focused Towards Developing Novel Vertigo Drug
Date: 27 November 2017

Vertigo is a medical condition where a person feels as if they or the objects around them are moving when they are not. Often it feels like a spinning or swaying movement. This may be associated with nausea, vomiting, sweating, or difficulties walking. It is typically worsened when the head is moved. Vertigo is the most common type of dizziness. The causes for vertigo can be divided into two categories: Peripheral and Central. Peripheral is linked to the inner ear whereas central is linked to problems in Central Nervous System.

 

Peripheral vertigo can be further segmented into five major categories: Benign paroxysmal positional vertigo (BPPV), Acute Unilateral Vestibulopathy, Meniere’s disease and Vestibular Schwannoma. Amongst all the stated indication, Meniere’s disease represents the largest growth opportunity for the market players with its continuously rising incidence.

 

The present medication for vertigo crisis does not provide an effective solution for the disorder. All of the drugs presently available to treat acute vertigo episodes have sedative effects, which impairs central compensation mechanisms and the patient’s ability to function normally while being treated. Companies have realized the need for an effective solution and are spending heavily on research and development of a novel therapy in order to reap the first mover’s advantage. This could be seen in the R&D expenditure of the major players involved in development process.

 

The report “Global Vertigo Market: Industry Analysis & Outlook (2017-2021)” analyzes the development of this market, with focus on Europe and US regions. The major trends, growth drivers as well as issues being faced by the market are discussed in detail in this report. The four major players involved in the development of breakthrough drug therapy for vertigo: Auris Medical Holding AG., Sensorion SA, Otonomy, Inc. and Sound Pharmaceuticals, Inc. are being profiled along with their key financials and strategies for growth.

 

 
About Us    |    PRESS RELEASES    |    Research Reports    |    Contact Us    |    PRIVACY POLICY    |    REFUND POLICY
@ Copyright 2014 Koncept Analytics Pvt Ltd. All Rights Reserved. Web Developed By Vision IT Consultants Pvt Ltd.